Table of Contents

• 1.1 List of Tables 7
• 1.2 List of Figures 11

2 Introduction 13

• 2.1 Topical Absorbable Hemostats Overview 13

3 Products under Development 14

• 3.1 Topical Absorbable Hemostats - Pipeline Products by Stage of Development 14
• 3.2 Topical Absorbable Hemostats - Pipeline Products by Segment 15
• 3.3 Topical Absorbable Hemostats - Pipeline Products by Territory 16
• 3.4 Topical Absorbable Hemostats - Pipeline Products by Regulatory Path 17
• 3.5 Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date 18
• 3.6 Topical Absorbable Hemostats - Ongoing Clinical Trials 19

4 Topical Absorbable Hemostats - Pipeline Products under Development by Companies 20

• 4.1 Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development 20
• 4.2 Topical Absorbable Hemostats - Pipeline Products by Stage of Development 22

5 Topical Absorbable Hemostats Companies and Product Overview 24

• 5.1 3-D Matrix Ltd Company Overview 24
• 5.2 Angiotech Pharmaceuticals Inc Company Overview 30
• 5.3 Anika Therapeutics Inc Company Overview 31
• 5.4 APRUS Bio-Medical Innovations Pvt Ltd Company Overview 32
• 5.5 Arch Therapeutics Inc Company Overview 33
• 5.6 Baxter Healthcare Corp Company Overview 38
• 5.7 Baxter International Inc Company Overview 39
• 5.8 Beth Israel Deaconess Medical Center Inc Company Overview 52
• 5.9 Biomedica Management Corp Company Overview 53
• 5.10 Biom'Up SAS Company Overview 56
• 5.11 C. R. Bard Inc Company Overview 57
• 5.12 Cellphire Inc Company Overview 59
• 5.13 Ceramicos Para Aplicacoes Medicas SA Company Overview 63
• 5.14 Columbia University Company Overview 64
• 5.15 Covalent Medical, Inc. (Inactive) Company Overview 65
• 5.16 Covalon Technologies Ltd Company Overview 66
• 5.17 Cresilon Inc Company Overview 68
• 5.18 CryoLife Inc Company Overview 70
• 5.19 Endomedix Incorporated Company Overview 71
• 5.20 Entegrion Inc Company Overview 73
• 5.21 Ethicon US LLC Company Overview 74
• 5.22 ETX Pharma Inc Company Overview 76
• 5.23 Gamma Therapeutics Inc Company Overview 77
• 5.24 GATT Technologies BV Company Overview 78
• 5.25 gel-e Inc Company Overview 80
• 5.26 Haemostatix Ltd Company Overview 82
• 5.27 Hemostasis LLC Company Overview 84
• 5.28 HLL Lifecare Ltd Company Overview 86
• 5.29 Keratin Biosciences Inc Company Overview 87
• 5.30 Leader Biomedical Europe BV Company Overview 88
• 5.31 LifeBond Ltd Company Overview 89
• 5.32 Protege Biomedical Company Overview 90
• 5.33 Resorba GmbH Company Overview 91
• 5.34 Rice University Company Overview 93
• 5.35 Sanara MedTech Inc Company Overview 94
• 5.36 Sanofi Biosurgery Inc Company Overview 95
• 5.37 Sea Run Holdings Inc Company Overview 97
• 5.38 St Teresa Medical Inc Company Overview 98
• 5.39 Tectum Company Overview 100
• 5.40 The Medicines Company Company Overview 102
• 5.41 Therus Corporation Company Overview 103
• 5.42 Thrombotargets Corp Company Overview 104
• 5.43 United Health Products, Inc. Company Overview 108
• 5.44 University of Grenoble Alpes Company Overview 111
• 5.45 Virginia Commonwealth University Company Overview 112
• 5.46 Xcede Technologies Inc Company Overview 113

6 Topical Absorbable Hemostats- Recent Developments 116

• 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 116
• 6.2 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 118
• 6.3 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn 119
• 6.4 Oct 31, 2019: gel-e announces breakthrough status designation from the U.S. Food and Drug Administration (FDA) for its first internal-use flowable device 119
• 6.5 Oct 31, 2019: Sanofi Q3 well on track 120
• 6.6 Oct 30, 2019: The Medicines Company reports third-quarter 2019 financial results and achievement of major milestones for inclisiran 123
• 6.7 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 125
• 6.8 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 126
• 6.9 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results 129
• 6.10 Oct 24, 2019: Anika reports third quarter 2019 financial results 131

7 Appendix 293

• 7.1 Methodology 293
• 7.2 About GlobalData 296
• 7.3 Contact Us 296

Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2019" provides an overview of Topical Absorbable Hemostats currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Topical Absorbable Hemostats pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Topical Absorbable Hemostats under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Topical Absorbable Hemostats and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Topical Absorbable Hemostats under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date